1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Over-The-Counter (OTC) Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cold and Flu Products
1.4.3 Analgesics
1.4.4 Dermatological Products
1.4.5 Gastrointestinal Products
1.4.6 Vitamin
1.4.7 Other
1.5 Market by Application
1.5.1 Global Over-The-Counter (OTC) Drugs Market Share by Application: 2021-2026
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Over-The-Counter (OTC) Drugs Market
1.8.1 Global Over-The-Counter (OTC) Drugs Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Over-The-Counter (OTC) Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Over-The-Counter (OTC) Drugs Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Over-The-Counter (OTC) Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Over-The-Counter (OTC) Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Over-The-Counter (OTC) Drugs Sales Volume Market Share by Region (2015-2020)
3.2 Global Over-The-Counter (OTC) Drugs Sales Revenue Market Share by Region (2015-2020)
3.3 North America Over-The-Counter (OTC) Drugs Sales Volume
3.3.1 North America Over-The-Counter (OTC) Drugs Sales Volume Growth Rate (2015-2020)
3.3.2 North America Over-The-Counter (OTC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Over-The-Counter (OTC) Drugs Sales Volume
3.4.1 East Asia Over-The-Counter (OTC) Drugs Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Over-The-Counter (OTC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Over-The-Counter (OTC) Drugs Sales Volume (2015-2020)
3.5.1 Europe Over-The-Counter (OTC) Drugs Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Over-The-Counter (OTC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Over-The-Counter (OTC) Drugs Sales Volume (2015-2020)
3.6.1 South Asia Over-The-Counter (OTC) Drugs Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Over-The-Counter (OTC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Over-The-Counter (OTC) Drugs Sales Volume (2015-2020)
3.7.1 Southeast Asia Over-The-Counter (OTC) Drugs Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Over-The-Counter (OTC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Over-The-Counter (OTC) Drugs Sales Volume (2015-2020)
3.8.1 Middle East Over-The-Counter (OTC) Drugs Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Over-The-Counter (OTC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Over-The-Counter (OTC) Drugs Sales Volume (2015-2020)
3.9.1 Africa Over-The-Counter (OTC) Drugs Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Over-The-Counter (OTC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Over-The-Counter (OTC) Drugs Sales Volume (2015-2020)
3.10.1 Oceania Over-The-Counter (OTC) Drugs Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Over-The-Counter (OTC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Over-The-Counter (OTC) Drugs Sales Volume (2015-2020)
3.11.1 South America Over-The-Counter (OTC) Drugs Sales Volume Growth Rate (2015-2020)
3.11.2 South America Over-The-Counter (OTC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Over-The-Counter (OTC) Drugs Sales Volume (2015-2020)
3.12.1 Rest of the World Over-The-Counter (OTC) Drugs Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Over-The-Counter (OTC) Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Over-The-Counter (OTC) Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Over-The-Counter (OTC) Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Over-The-Counter (OTC) Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Over-The-Counter (OTC) Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Over-The-Counter (OTC) Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Over-The-Counter (OTC) Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Over-The-Counter (OTC) Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Over-The-Counter (OTC) Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Over-The-Counter (OTC) Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Over-The-Counter (OTC) Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Over-The-Counter (OTC) Drugs Sales Volume Market Share by Type (2015-2020)
14.2 Global Over-The-Counter (OTC) Drugs Sales Revenue Market Share by Type (2015-2020)
14.3 Global Over-The-Counter (OTC) Drugs Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Over-The-Counter (OTC) Drugs Consumption Volume by Application (2015-2020)
15.2 Global Over-The-Counter (OTC) Drugs Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Over-The-Counter (OTC) Drugs Business
16.1 Bayer
16.1.1 Bayer Company Profile
16.1.2 Bayer Over-The-Counter (OTC) Drugs Product Specification
16.1.3 Bayer Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Teva Pharmaceuticals
16.2.1 Teva Pharmaceuticals Company Profile
16.2.2 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product Specification
16.2.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Novartis
16.3.1 Novartis Company Profile
16.3.2 Novartis Over-The-Counter (OTC) Drugs Product Specification
16.3.3 Novartis Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Boehringer Ingelheim
16.4.1 Boehringer Ingelheim Company Profile
16.4.2 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product Specification
16.4.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Sanofi
16.5.1 Sanofi Company Profile
16.5.2 Sanofi Over-The-Counter (OTC) Drugs Product Specification
16.5.3 Sanofi Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 GSK
16.6.1 GSK Company Profile
16.6.2 GSK Over-The-Counter (OTC) Drugs Product Specification
16.6.3 GSK Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Cipla
16.7.1 Cipla Company Profile
16.7.2 Cipla Over-The-Counter (OTC) Drugs Product Specification
16.7.3 Cipla Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 PGT healthcare
16.8.1 PGT healthcare Company Profile
16.8.2 PGT healthcare Over-The-Counter (OTC) Drugs Product Specification
16.8.3 PGT healthcare Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Pfizer
16.9.1 Pfizer Company Profile
16.9.2 Pfizer Over-The-Counter (OTC) Drugs Product Specification
16.9.3 Pfizer Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Takeda
16.10.1 Takeda Company Profile
16.10.2 Takeda Over-The-Counter (OTC) Drugs Product Specification
16.10.3 Takeda Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Sun Pharmaceutical Industries
16.11.1 Sun Pharmaceutical Industries Company Profile
16.11.2 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product Specification
16.11.3 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Glenmark
16.12.1 Glenmark Company Profile
16.12.2 Glenmark Over-The-Counter (OTC) Drugs Product Specification
16.12.3 Glenmark Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Innovus Pharmaceuticals
16.13.1 Innovus Pharmaceuticals Company Profile
16.13.2 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product Specification
16.13.3 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Over-The-Counter (OTC) Drugs Manufacturing Cost Analysis
17.1 Over-The-Counter (OTC) Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Over-The-Counter (OTC) Drugs
17.4 Over-The-Counter (OTC) Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Over-The-Counter (OTC) Drugs Distributors List
18.3 Over-The-Counter (OTC) Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Over-The-Counter (OTC) Drugs (2021-2026)
20.2 Global Forecasted Revenue of Over-The-Counter (OTC) Drugs (2021-2026)
20.3 Global Forecasted Price of Over-The-Counter (OTC) Drugs (2015-2026)
20.4 Global Forecasted Production of Over-The-Counter (OTC) Drugs by Region (2021-2026)
20.4.1 North America Over-The-Counter (OTC) Drugs Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Over-The-Counter (OTC) Drugs Production, Revenue Forecast (2021-2026)
20.4.3 Europe Over-The-Counter (OTC) Drugs Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Over-The-Counter (OTC) Drugs Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Over-The-Counter (OTC) Drugs Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Over-The-Counter (OTC) Drugs Production, Revenue Forecast (2021-2026)
20.4.7 Africa Over-The-Counter (OTC) Drugs Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Over-The-Counter (OTC) Drugs Production, Revenue Forecast (2021-2026)
20.4.9 South America Over-The-Counter (OTC) Drugs Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Over-The-Counter (OTC) Drugs Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Over-The-Counter (OTC) Drugs by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Over-The-Counter (OTC) Drugs by Country
21.2 East Asia Market Forecasted Consumption of Over-The-Counter (OTC) Drugs by Country
21.3 Europe Market Forecasted Consumption of Over-The-Counter (OTC) Drugs by Countriy
21.4 South Asia Forecasted Consumption of Over-The-Counter (OTC) Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Over-The-Counter (OTC) Drugs by Country
21.6 Middle East Forecasted Consumption of Over-The-Counter (OTC) Drugs by Country
21.7 Africa Forecasted Consumption of Over-The-Counter (OTC) Drugs by Country
21.8 Oceania Forecasted Consumption of Over-The-Counter (OTC) Drugs by Country
21.9 South America Forecasted Consumption of Over-The-Counter (OTC) Drugs by Country
21.10 Rest of the world Forecasted Consumption of Over-The-Counter (OTC) Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer